1. Borzekowski DL, Guan Y, Smith KC, Erby LH, Roter DL. The Angelina effect: immediate reach, grasp, and impact of going public. Genet Med. 2014;16(7):516–21.
2. Bakos AD, Hutson SP, Loud JT, Peters JA, Giusti RM, Greene MH. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience. Health Expect. 2008;11(3):220–31.
3. Macrae L, de Souza AN, Loiselle CG, Wong N. Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study. Hered Cancer Clin Pract. 2013;11(1):14.
4. Gavaruzzi T, Tasso A, Franiuk M, Varesco L, Lotto L. Are young women ready for BRCA testing? Comparing attitudes and comprehension of two age groups of healthy Italian women. Patient Educ Couns. 2019;102(6):1210–6.
5. Guan Y, Condit CM, Escoffery C, Bellcross CA, McBride CM. Do women who receive a negative BRCA1/2 risk result understand the implications for breast cancer risk? Public Health Genomics. 2019;22(3–4):102–9.